Connect Biopharma Holdings Ltd (CNTB NASDAQ) stock market data APIs
$2.5272
-0.26(-10.3%)
as of December 22, 2025
Try our APIs with
free plan!
Connect Biopharma Holdings Ltd Financial Data Overview
Price chart is built with
Anychart
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.
Prev. Close
2.5272
Open
2.266
High
2.6651
Low
2.2333
52 wk Range
0.51-3.28
Market Cap
142 M
Shares Outstanding
55 904 K
Revenue
762 K
EPS
-0.31
Beta
-0.185
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Connect Biopharma Holdings Ltd data using free add-ons & libraries
Get Connect Biopharma Holdings Ltd Fundamental Data
Connect Biopharma Holdings Ltd Fundamental data includes:
- Net Revenue: 762 K
- EBITDA: -54 686 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-12-03
- EPS/Forecast: -0.24
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Connect Biopharma Holdings Ltd News
New
Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks
As the U.S. stock market continues to rally, with major indexes like the S&P 500 and Dow Jones nearing record highs, investors are increasingly looking for opportunities in less traditional areas. Pen...
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical comp...
Relmada Therapeutics Leads These 3 Promising Penny Stocks
On November 4, 2025, major U.S. stock indexes closed sharply lower, with tech stocks leading the decline and Bitcoin experiencing a notable drop. In such volatile market conditions, investors often se...
October 2025's Promising Penny Stocks To Consider
As U.S. stock indexes continue to rise, even amid a government shutdown, investors are keeping a close eye on market dynamics and economic indicators. In this context, penny stocks—despite the somew...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
